| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |